Matches in Nanopublications for { ?s ?p "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP263783.RASz0bub5lPDAKLCZKeF90g9xF58yhg4FJTcA8NCFdgVA130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263783.RASz0bub5lPDAKLCZKeF90g9xF58yhg4FJTcA8NCFdgVA130_provenance.
- NP530817.RAl-bzB3-brBUUAdyS4G9ilqJIZ1L3w-RgRvChZgxtRsY130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530817.RAl-bzB3-brBUUAdyS4G9ilqJIZ1L3w-RgRvChZgxtRsY130_provenance.
- NP789778.RARLURERHvWgRhEzWCztG_4HVrJxqhF2LBbRThXlLnx90130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789778.RARLURERHvWgRhEzWCztG_4HVrJxqhF2LBbRThXlLnx90130_provenance.
- NP898606.RAmlg4VhkZVbvPrm_7rsRUxVJVsVkVclO1h2ZTNLUV3H4130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898606.RAmlg4VhkZVbvPrm_7rsRUxVJVsVkVclO1h2ZTNLUV3H4130_provenance.
- NP614088.RAt49AfPMjzviw1Vwf15KpiWfq6dF0cCej9LmXqN0b6NQ130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614088.RAt49AfPMjzviw1Vwf15KpiWfq6dF0cCej9LmXqN0b6NQ130_provenance.
- NP719934.RAiOg8MWkQhlkfKP_M4wP-IoOd-1npBGGKFh64Pmu0llY130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719934.RAiOg8MWkQhlkfKP_M4wP-IoOd-1npBGGKFh64Pmu0llY130_provenance.
- NP727876.RA4FmKU10U64_EmDcvPUHXexrUdf4TVFGeo4PbTLXjy5k130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727876.RA4FmKU10U64_EmDcvPUHXexrUdf4TVFGeo4PbTLXjy5k130_provenance.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_provenance.
- NP908659.RA7pCdb8FN7S6kX6RwA7qKpN37tl1z8yYJ_rrseBT_-dY130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908659.RA7pCdb8FN7S6kX6RwA7qKpN37tl1z8yYJ_rrseBT_-dY130_provenance.
- NP793571.RAHeshS-tmGOPi1GcIIa68ZVgEPFEbHnTrj7EP1jrOfyo130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793571.RAHeshS-tmGOPi1GcIIa68ZVgEPFEbHnTrj7EP1jrOfyo130_provenance.
- assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.